The OECD.AI Policy Navigator

Our policy navigator is a living repository from more than 80 jurisdictions and organisations. Use the filters to browse initiatives and find what you are looking for.

E-prescriptions


Added by:   National contact point
Added on:   07 Oct 2025
Updated by:   OECD analyst
Updated on:   25 Dec 2025

E-prescriptions are the second action within the National eHealth Strategy for the period 2016–2020. Within this action, Phase I (a gradual move to full-scale electronic prescriptions) was introduced and then the legal obligation to create medical prescriptions only in electronic form, the so-called electronic prescription, was introduced on 1 January 2018.

Name in original language

-

Initiative overview

Electronic prescription and the implementation of the ePrescription information system are based in legislation – Act No 378/2007 Coll., on Pharmaceuticals, as amended. The doctor issues an electronic prescription (ePrescription) for the patient and on the basis of the ePrescription, the pharmacy dispenses the medicinal product. The Central Repository of Electronic Prescriptions (“CÚER”), as one of the components of the ePrescription system, collects and stores all ePrescriptions under conditions stipulated by effective legislation. The implemented ePrescription system is one of the provided eHealth services and its operation in the Czech Republic has been mandatory since 1 January 2018. Section 81f of Act No 378/2007 Coll., on Pharmaceuticals, permits certain exceptional situations in which it is still possible to issue paper prescriptions.

Name of responsible organisation (in English)

State Institute for Drug Control

About the policy initiative


Organisation:

  • State Institute for Drug Control

Category:

  • AI policy initiatives, programmes and projects

Initiative type:

  • Initiative/Investment in natural language processing

Status:

  • Inactive – initiative complete

Start Year:

  • 2018

End Year:

  • 2020

Binding:

  • Non-binding

Other relevant urls: